Literature DB >> 23677524

Receipt of recommended surveillance among colorectal cancer survivors: a systematic review.

Melissa Y Carpentier1, Sally W Vernon, L Kay Bartholomew, Caitlin C Murphy, Shirley M Bluethmann.   

Abstract

PURPOSE: Regular surveillance decreases the risk of recurrent cancer in colorectal cancer (CRC) survivors. However, studies suggest that receipt of follow-up tests is not consistent with guidelines. This systematic review aimed to: (1) examine receipt of recommended post-treatment surveillance tests and procedures among CRC survivors, including adherence to established guidelines, and (2) identify correlates of CRC surveillance.
METHODS: Systematic searches of Medline, PubMed, PsycINFO, CINAHL Plus, and Scopus databases were conducted using terms adapted for each database's keywords and subject headings. Studies were screened for inclusion using a three-step process: (1) lead author reviewed abstracts of all eligible studies; (2) coauthors reviewed random 5 % samples of abstracts; and (3) two sets of coauthors reviewed all "maybe" abstracts. Discrepancies were adjudicated through discussion.
RESULTS: Thirty-four studies are included in the review. Overall adherence ranged from 12 to 87 %. Within the initial 12 to 18 months post-treatment, adherence to recommended office visits was 93 %. Adherence ranged from 78 to 98 % for physical exams, 18-61 % for colonoscopy, and 17-71 % for carcinoembryonic antigen (CEA) testing. By 2 to 3 years post-treatment, cumulative adherence ranged from 70 to 88 % for office visits, 89-93 % for physical exams, 49-94 % for colonoscopy, and 7-79 % for CEA testing. Between 18 and 28 % of CRC survivors received greater than recommended overall surveillance; overuse of physical exams (42 %), colonoscopy (24-76 %), and metastatic disease testing (1-29 %) was also prevalent. Studies of correlates of CRC surveillance focused on sociodemographic and disease/treatment characteristics, and patterns of association were inconsistent across studies.
CONCLUSIONS: Deviation from surveillance recommendations includes both under- and overuse. Examination of modifiable determinants is needed to inform interventions targeting appropriate and timely receipt of recommended surveillance. IMPLICATIONS FOR CANCER SURVIVORS: Among CRC survivors, it remains unclear what modifiable psychosocial factors are associated with the observed under- and overuse of surveillance. Understanding and intervening with these psychosocial factors is critical to improving adherence to guideline-recommended surveillance and thereby reducing mortality among this group of survivors.

Entities:  

Mesh:

Year:  2013        PMID: 23677524      PMCID: PMC3737369          DOI: 10.1007/s11764-013-0290-x

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  66 in total

Review 1.  Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Authors:  M Jeffery; B E Hickey; P N Hider
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Taking CHARGE: A self-management program for women following breast cancer treatment.

Authors:  Bernadine Cimprich; Nancy K Janz; Laurel Northouse; Patricia A Wren; Barbara Given; Charles W Given
Journal:  Psychooncology       Date:  2005-09       Impact factor: 3.894

3.  Screening colonoscopy among colorectal cancer survivors insured by Medicaid.

Authors:  Kristie Long Foley; Eun-Young Song; Heidi Klepin; Ann Geiger; Janet Tooze
Journal:  Am J Clin Oncol       Date:  2012-06       Impact factor: 2.339

4.  Geographic and patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma.

Authors:  G S Cooper; Z Yuan; A Chak; A A Rimm
Journal:  Cancer       Date:  1999-05-15       Impact factor: 6.860

5.  Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors.

Authors:  Arnold L Potosky; Paul K J Han; Julia Rowland; Carrie N Klabunde; Tenbroeck Smith; Noreen Aziz; Craig Earle; John Z Ayanian; Patricia A Ganz; Michael Stefanek
Journal:  J Gen Intern Med       Date:  2011-07-22       Impact factor: 5.128

6.  The role of postoperative surveillance in colorectal cancer.

Authors:  Kerry Hammond; David A Margolin
Journal:  Clin Colon Rectal Surg       Date:  2007-08

7.  Quality of cancer survivorship care in the military health system (TRICARE).

Authors:  Justin P Fox; Diana D Jeffery; Thomas V Williams; Cary P Gross
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

8.  Cost and effectiveness of follow-up examinations in patients with colorectal cancer resected for cure in a French population-based study.

Authors:  Frédéric Borie; Jean-Pierre Daurès; Bertrand Millat; Brigitte Trétarre
Journal:  J Gastrointest Surg       Date:  2004 Jul-Aug       Impact factor: 3.452

9.  Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.

Authors:  Jennifer L Spratlin; David Hui; John Hanson; Charles Butts; Heather-Jane Au
Journal:  Clin Colorectal Cancer       Date:  2008-03       Impact factor: 4.481

Review 10.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  24 in total

Review 1.  A systematic review of patient perspectives on surveillance after colorectal cancer treatment.

Authors:  Julia R Berian; Amanda Cuddy; Amanda B Francescatti; Linda O'Dwyer; Y Nancy You; Robert J Volk; George J Chang
Journal:  J Cancer Surviv       Date:  2017-06-22       Impact factor: 4.442

2.  Examining Adherence With Recommendations for Follow-Up in the Prevention Among Colorectal Cancer Survivors Study.

Authors:  Nikki A Hawkins; Zahava Berkowitz; Juan Rodriguez; Jacqueline W Miller; Susan A Sabatino; Lori A Pollack
Journal:  Oncol Nurs Forum       Date:  2015-05       Impact factor: 2.172

3.  Understanding Long-Term Cancer Survivors' Preferences for Ongoing Medical Care.

Authors:  Tenbroeck G Smith; Sara Strollo; Xin Hu; Craig C Earle; Corinne R Leach; Larissa Nekhlyudov
Journal:  J Gen Intern Med       Date:  2019-07-31       Impact factor: 5.128

4.  Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.

Authors:  Fatih Safa Erenay; Oguzhan Alagoz; Ritesh Banerjee; Adnan Said; Robert R Cima
Journal:  Cancer       Date:  2016-06-01       Impact factor: 6.860

5.  Factors Associated With the Overuse of Colorectal Cancer Screening: A Systematic Review.

Authors:  Zachary Predmore; Jean Pannikottu; Ritu Sharma; Monica Tung; Stephanie Nothelle; Jodi B Segal
Journal:  Am J Med Qual       Date:  2018-03-16       Impact factor: 1.852

6.  A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.

Authors:  Caitlin C Murphy; Ahana Sen; Bianca Watson; Samir Gupta; Helen Mayo; Amit G Singal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-18       Impact factor: 4.254

7.  Surveillance instructions and knowledge among African American colorectal cancer survivors.

Authors:  Maria Pisu; Cheryl L Holt; Aquila Brown-Galvan; Temeika Fairley; Judith Lee Smith; Arica White; Ingrid J Hall; Robert A Oster; Michelle Y Martin
Journal:  J Oncol Pract       Date:  2014-01-02       Impact factor: 3.840

8.  Trends in surveillance for resected colorectal cancer, 2001-2009.

Authors:  E Carter Paulson; Christine M Veenstra; Anil Vachani; Christine A Ciunci; Andrew J Epstein
Journal:  Cancer       Date:  2015-06-16       Impact factor: 6.860

Review 9.  Colorectal cancer surveillance: what's new and what's next.

Authors:  Johnie Rose; Knut Magne Augestad; Gregory S Cooper
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

10.  Advancing Health Equity in Cancer Survivorship: Opportunities for Public Health.

Authors:  Judith Lee Smith; Ingrid J Hall
Journal:  Am J Prev Med       Date:  2015-12       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.